BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28686664)

  • 21. What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study.
    Puglisi S; Rossini A; Tabaro I; Cannavò S; Ferrau' F; Ragonese M; Borretta G; Pellegrino M; Dughera F; Parisi A; Latina A; Pia A; Terzolo M; Reimondo G
    J Endocrinol Invest; 2021 Apr; 44(4):865-872. PubMed ID: 32779106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized, double-blind, crossover study comparing two- and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency.
    Ekman B; Bachrach-Lindström M; Lindström T; Wahlberg J; Blomgren J; Arnqvist HJ
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):18-25. PubMed ID: 22288685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of hydrocortisone substitution on the quality of life and parameters of bone metabolism in patients with secondary hypocortisolism.
    Wichers M; Springer W; Bidlingmaier F; Klingmüller D
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):759-65. PubMed ID: 10468948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia.
    Merza Z; Rostami-Hodjegan A; Memmott A; Doane A; Ibbotson V; Newell-Price J; Tucker GT; Ross RJ
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between adrenal insufficiency and ventilator weaning.
    Huang CJ; Lin HC
    Am J Respir Crit Care Med; 2006 Feb; 173(3):276-80. PubMed ID: 16272449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Data of the quantitative orofacial somatosensory functions of healthy subjects and its influence factors analysis].
    Yang GJ; Cao Y; Zhang L; Qin XY; Xie QF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Jun; 47(3):521-528. PubMed ID: 26080887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Somatosensory Profiling of Patients with Burning Mouth Syndrome and Correlations with Psychologic Factors.
    Yang G; Su S; Jie H; Baad-Hansen L; Wang K; Yan S; Liu H; Xie QF; Svensson P
    J Oral Facial Pain Headache; 2019; 33(3):278–286. PubMed ID: 30893407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion.
    Bliesener N; Steckelbroeck S; Redel L; Klingmüller D
    Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):443-6. PubMed ID: 14614652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants.
    Efird MM; Heerens AT; Gordon PV; Bose CL; Young DA
    J Perinatol; 2005 Feb; 25(2):119-24. PubMed ID: 15329742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study on variability of quantitative sensory testing in healthy participants and painful temporomandibular disorder patients.
    Yang G; Baad-Hansen L; Wang K; Xie QF; Svensson P
    Somatosens Mot Res; 2014 Jun; 31(2):62-71. PubMed ID: 24397569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corticosteroid after etomidate in critically ill patients: a randomized controlled trial.
    Payen JF; Dupuis C; Trouve-Buisson T; Vinclair M; Broux C; Bouzat P; Genty C; Monneret D; Faure P; Chabre O; Bosson JL
    Crit Care Med; 2012 Jan; 40(1):29-35. PubMed ID: 21926601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated hair cortisol concentrations in children with adrenal insufficiency on hydrocortisone replacement therapy.
    Noppe G; van Rossum EF; Vliegenthart J; Koper JW; van den Akker EL
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):820-5. PubMed ID: 25039686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.
    Melin J; Parra-Guillen ZP; Hartung N; Huisinga W; Ross RJ; Whitaker MJ; Kloft C
    Clin Pharmacokinet; 2018 Apr; 57(4):515-527. PubMed ID: 28762136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Challenges of Cortisol Replacement Therapy in Childhood: Observations from a Case Series of Children Treated with Modified-Release Hydrocortisone.
    Park J; Das U; Didi M; Ramakrishnan R; Peak M; Newland P; Blair J
    Paediatr Drugs; 2018 Dec; 20(6):567-573. PubMed ID: 30088158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.
    Delle Cese F; Corsello A; Cintoni M; Locantore P; Pontecorvi A; Corsello SM; Paragliola RM
    Front Endocrinol (Lausanne); 2020; 11():610904. PubMed ID: 33597926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency.
    Nilsson AG; Marelli C; Fitts D; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Lennernäs H; Skrtic S; Johannsson G
    Eur J Endocrinol; 2014 Sep; 171(3):369-77. PubMed ID: 24944332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Daily Glucocorticoid Replacement Dose in Adrenal Insufficiency, a Mini Review.
    Caetano CM; Malchoff CD
    Front Endocrinol (Lausanne); 2022; 13():897211. PubMed ID: 35846313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin concentrations.
    Chung TT; Gunganah K; Monson JP; Drake WM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):496-500. PubMed ID: 26603673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic Modeling of Hydrocortisone by Including Protein Binding to Corticosteroid-Binding Globulin.
    Rozenveld E; Punt N; van Faassen M; van Beek AP; Touw DJ
    Pharmaceutics; 2022 May; 14(6):. PubMed ID: 35745734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.